A. Limitations
So far we have seen a new approach of using stemcells for targeting cancer site and a new concept of
treatment. However it might seem fascinating, it is important to note that significant impediments remain
before the true potential of this novel therapy can be fully realized. Here in this section we are going to
mainly focus on the limitations of neural stemcells esp
cells
How to think?
Active factor(protein) in ES cells skin cells
Aug, 2006, Pro. Yamanaka ’s laboratory in Kyoto produced ‘pluripotent cells’
Nov, 2007, the first Human iPS cells
iPS cells are a type of pluripotent stemcell
artificially derived from a differentiated cell,
by inducing a “forced” expression of Certain genes!
Mechanism of
cancer pr
cells ≠ Stemcells from a fetus.
Have a great outcome that they outweigh the ethical issues.
The research would give great insights
about the basics of the body.
* Parkinson’s , Alzheimer’s Disease
* Heart Diseases, Stroke and Diabetes
* Birth Defects
* Spinal Cord Injuries
* Replace Damaged Organs,
Play a major role in cancer
potentia
● 암의 유형에 따른 DNA 저메틸화의 두 가지 양상
○ 결장암의 경우에는 DNA 과다메틸화가 결장암 발병을 촉진하므로 저메틸화가 항암 효과를 지닌다는 것이 발표되었다. 과다메틸화가 결장암세포의 수를 60~100%까지 증가시켰으며 초기종양의 현미경상의 평균 크기도 증가시켰다. 이 연구는 과다메틸화
Mid-1800s - Beginning research of Embryo
1908 – ‘StemCell’ from Alexander Maksimov
1963 – Self reproducing cell
1978 – Found Blood stemcell
1981 - Embryonic stemcell
1998 - Human's embryonic stemcell
2001 – First human embryo cloning
(중략)
2.1 Adult StemCell - How?From Bone Marrow
HSCs and MSCs are rich in b